Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-12-024325
Filing Date
2012-04-17
Accepted
2012-04-17 16:23:58
Documents
1
Period of Report
2012-04-16

Document Format Files

Seq Description Document Type Size
1 WORTZMAN 4.16.12 rrd342239.html 4  
1 WORTZMAN 4.16.12 rrd342239.xml 4 6796
  Complete submission text file 0001181431-12-024325.txt   8161
Mailing Address 1003 W. CUTTING BLVD SUITE 110 POINT RICHMOND CA 94804
Business Address 1003 W. CUTTING BLVD SUITE 110 POINT RICHMOND CA 94804 (510) 215-3500
Transcept Pharmaceuticals Inc (Issuer) CIK: 0001178711 (see all company filings)

EIN.: 330960223 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address
Business Address
WORTZMAN MARILYN E (Reporting) CIK: 0001235962 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-51967 | Film No.: 12763976